Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,594 | 2,597 | 4,919 | 3,194 | 1,783 |
| TOTAL | $2,672 | $2,625 | $4,988 | $3,310 | $1,850 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,672 | $2,625 | $4,988 | $3,310 | $1,850 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 800 | 944 | 1,114 | 999 | 610 |
| Other current liabilities | 16 | 29 | 47 | 413 | 586 |
| TOTAL | $816 | $973 | $1,161 | $1,412 | $1,196 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 15 | 11 | 9 | 9 | 23 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $816 | $973 | $1,161 | $1,412 | $1,196 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,150 | 1,912 | 1,431 | 941 | 589 |
| Common Shares | N/A | N/A | N/A | N/A | 3 |
| Retained earnings | -102,580 | -101,036 | -97,960 | -95,268 | -90,928 |
| Other shareholders' equity | -941 | -958 | -937 | -938 | -928 |
| TOTAL | $1,856 | $1,652 | $3,827 | $1,898 | $654 |
| Total Liabilities And Equity | $2,672 | $2,625 | $4,988 | $3,310 | $1,850 |